TSX
-
S&P/TSX Composite Climbs as U.S. Pauses Tariff Implementation
The S&P/TSX Composite rose to 36,500 after the U.S. paused 50% tariffs on Canadian goods, fueling gains in energy and mining stocks amid trade stability.
-
TSX Gains Momentum Amid Q2 Earnings Beats and Tech Sector Strength
The S&P/TSX Composite Index rose on Tuesday, bolstered by strong technology sector performance and robust Q2 earnings reports from firms like Celestica.
-
Cadillac Mines Plans Major TSX IPO to Raise C$363 Million
Toronto-based Cadillac Mines is targeting a C$363 million TSX IPO, backed by major industry players to advance exploration at the historic Kerr-Addison gold mine.
-
Enbridge Targets Long-Term Growth Amid Stable Valuation
Enbridge Inc. plans $11 billion in annual infrastructure investment through 2030, balancing ambitious growth projects with a stable debt profile.
-
Enbridge Consolidates Debt as Stock Enters Range-Bound Consolidation
Enbridge Inc. has completed a strategic note exchange to lower financing costs, while its stock faces mixed technical signals and range-bound trading between C$77.23 and C$80.25.
-
TSX Reaches Record High as Oil Prices Ease Following U.S.-Iran Peace Deal
The Toronto Stock Exchange hit a record high today as Brent crude prices dipped to $83.17 following a U.S.-Iran peace deal, though analysts warn that elevated fuel costs for Canadians are likely to persist.
-
TSX Composite Index Hits Record High Following Geopolitical De-escalation
The S&P/TSX Composite Index reached a new record high as markets responded to a preliminary agreement aimed at reopening the Strait of Hormuz and ending regional hostilities.
-
Bank of Nova Scotia Hits 52-Week Highs Amid Overbought Technical Signals
Bank of Nova Scotia (BNS) has reached new 52-week highs, ranking among the top TSX performers for momentum, though technical indicators suggest the stock may be overextended.
-
Apotex Health Prices Upsized IPO at $1.3 Billion, Marking Landmark TSX Debut
Canadian pharmaceutical giant Apotex Health has successfully priced its IPO at $24 per share, raising $1.3 billion and signaling a major resurgence for the Toronto Stock Exchange.
-
Xanadu Shares Debut on TSX: What Investors Should Know
Xanadu Quantum Technologies has officially begun trading on the Toronto Stock Exchange, marking the first public offering for a pure-play photonic quantum computing firm.
-
Boralex to Go Private in $9B Deal with Brookfield, La Caisse
Boralex will be acquired for $9 billion by Brookfield and La Caisse. The deal includes a 31.8% premium and delisting from the TSX by late 2026.
-
Dollarama Shares Slip as Sales Forecast Misses Targets
Dollarama Inc. shares fell Tuesday after the retailer issued a conservative fiscal 2027 sales growth forecast and reported a dip in Canadian store traffic.
-
Constellation Software Stock Nears 52-Week Low Amid Market Debate
Constellation Software (CSU) shares are trading near their 52-week low on February 4, 2026, down 51% from their peak, as investors grapple with AI disruption fears and a broader software valuation reset.
-
CNR Stock: Is Canadian National Railway a Buy at Today’s Discounted Price?
Canadian National Railway stock is trading near its 52-week low, sparking renewed interest among long-term investors. With trade tensions affecting performance but fundamentals remaining strong, is now the time to add CNR to your portfolio?